SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BERNARDI, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.785
AS - Asia 19.615
EU - Europa 12.202
SA - Sud America 3.015
AF - Africa 454
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 18
AN - Antartide 1
Totale 71.130
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 35.022
SG - Singapore 7.385
CN - Cina 4.967
FI - Finlandia 2.585
BR - Brasile 2.344
VN - Vietnam 2.335
DE - Germania 2.090
UA - Ucraina 1.761
IT - Italia 1.716
HK - Hong Kong 1.556
TR - Turchia 1.138
GB - Regno Unito 1.050
FR - Francia 623
PL - Polonia 563
JP - Giappone 530
RU - Federazione Russa 499
SE - Svezia 493
IN - India 379
CA - Canada 345
MX - Messico 314
ID - Indonesia 257
AR - Argentina 237
BD - Bangladesh 223
ZA - Sudafrica 170
NL - Olanda 160
IQ - Iraq 141
ES - Italia 133
BE - Belgio 106
EC - Ecuador 103
PK - Pakistan 93
CO - Colombia 88
VE - Venezuela 80
UZ - Uzbekistan 72
MY - Malesia 67
CZ - Repubblica Ceca 64
MA - Marocco 63
AT - Austria 60
LT - Lituania 57
SA - Arabia Saudita 57
CL - Cile 54
PH - Filippine 53
KE - Kenya 51
IR - Iran 40
PY - Paraguay 37
PE - Perù 35
JO - Giordania 34
TN - Tunisia 34
AU - Australia 33
IE - Irlanda 32
AE - Emirati Arabi Uniti 31
NP - Nepal 31
CH - Svizzera 27
DZ - Algeria 25
IL - Israele 25
JM - Giamaica 22
RO - Romania 22
AL - Albania 21
AZ - Azerbaigian 21
UY - Uruguay 21
ET - Etiopia 20
EG - Egitto 19
KR - Corea 19
TH - Thailandia 19
TW - Taiwan 19
CR - Costa Rica 18
GR - Grecia 18
PT - Portogallo 18
KZ - Kazakistan 14
OM - Oman 14
PS - Palestinian Territory 14
BG - Bulgaria 13
SN - Senegal 13
DO - Repubblica Dominicana 12
EU - Europa 12
NO - Norvegia 12
RS - Serbia 12
BO - Bolivia 11
NG - Nigeria 11
GE - Georgia 10
LB - Libano 10
BH - Bahrain 9
KG - Kirghizistan 9
PA - Panama 9
SK - Slovacchia (Repubblica Slovacca) 9
KW - Kuwait 8
TT - Trinidad e Tobago 8
BY - Bielorussia 7
CI - Costa d'Avorio 7
DK - Danimarca 7
HN - Honduras 7
HU - Ungheria 7
NZ - Nuova Zelanda 7
BA - Bosnia-Erzegovina 6
GT - Guatemala 6
NI - Nicaragua 6
AF - Afghanistan, Repubblica islamica di 5
AO - Angola 5
BW - Botswana 5
GA - Gabon 5
KH - Cambogia 5
Totale 71.020
Salva come PNG Salva come JPEG
Città #
Singapore 4.535
Ashburn 3.720
Woodbridge 2.988
Fairfield 2.928
Helsinki 2.130
San Jose 2.106
Chandler 1.929
Houston 1.921
Jacksonville 1.838
Santa Clara 1.602
Hong Kong 1.516
Beijing 1.499
Ann Arbor 1.407
Seattle 1.209
Wilmington 1.112
Cambridge 962
Dallas 934
Ho Chi Minh City 796
Izmir 633
New York 611
Nanjing 572
Warsaw 544
Hanoi 539
Los Angeles 532
Ferrara 524
Munich 519
Tokyo 504
Princeton 437
Boardman 405
Lauterbourg 370
The Dalles 297
San Diego 276
Council Bluffs 256
São Paulo 233
Milan 225
Shanghai 218
Mexico City 206
Orem 190
Dearborn 173
Nanchang 173
Shenyang 171
Jakarta 170
Bremen 162
London 157
Tianjin 142
Buffalo 140
Chicago 126
Hebei 120
Brooklyn 113
Hefei 112
Jiaxing 110
Montreal 109
Toronto 109
Da Nang 106
Frankfurt am Main 105
Falls Church 104
Changsha 101
Turku 99
Brussels 97
Chennai 97
Denver 97
Johannesburg 97
Haiphong 91
Redwood City 86
Jinan 83
Falkenstein 75
Moscow 75
Atlanta 74
Rio de Janeiro 74
Norwalk 73
Rome 73
San Mateo 71
Stockholm 70
Amsterdam 69
Kunming 68
Manchester 65
Mountain View 65
Phoenix 65
Tashkent 64
Guangzhou 63
Poplar 60
San Francisco 60
Belo Horizonte 58
Nuremberg 58
Baghdad 57
Düsseldorf 57
Curitiba 52
Zhengzhou 50
Auburn Hills 49
Biên Hòa 48
Brno 48
Hải Dương 46
Boston 45
Dong Ket 44
Nairobi 44
Des Moines 43
Addison 42
Brasília 42
Hangzhou 41
Ankara 39
Totale 48.500
Salva come PNG Salva come JPEG
Nome #
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B 2.045
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System 421
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 346
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 317
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 300
Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides 298
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 296
AN EXON-SPECIFIC U1 SMALL NUCLEAR RNA (snRNA) STRATEGY TO CORRECT SPLICING MUTATIONS ASSOCIATED TO HEMOPHILIA B 294
An exon-specific U1snRNA induces a robust factor IX activity in mice expressing multiple human FIX splicing mutants 291
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 285
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 283
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 278
Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy 278
A highly polymorphic microsatellite in the factor V gene is an informative tool for the study of factor V-related disorders 261
A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates 259
Hemostasis biomarkers in multiple sclerosis 255
Characterization of a deleted Y chromosome in a male with Turner stigmata 253
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 250
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 248
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 246
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 246
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 246
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 245
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 243
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family 241
Analisi dei multimeri del fattore von Willebrand mediante doppia immunoprecipitazione dopo elettroforesi su gel di agarosio. 241
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 241
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 241
Attività sulla emostasi di alcune piante della medicina tradizionale indiana 238
A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype 238
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 238
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 237
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 237
Chronic sleep deprivation markedly reduces coagulation factor VII expression 237
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 237
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 237
Membrane binding and anticoagulant properties of protein S natural variants 235
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 235
Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant 234
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 233
High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: A fatigue-metabolism nexus? 232
A NEW DISEASE-CAUSING MUTATION IN THE GAP-RELATED DOMAIN OF THE NF1 GENE 229
An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A 228
Moderate alcohol intake and hemostatic and inflammatory markers in middle-aged women: a controlled study 226
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 225
Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity 223
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 223
Evidence for an overlapping role of clock and npas2 transcription factors in liver circadian oscillators 221
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 220
An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects 218
c-myc oncogene alterations in human thyroid carcinomas. 218
A missense mutation (Y1702C) in the coagulation factor V gene is a frequent cause of factor V deficiency in the italian population 217
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 216
Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 213
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 212
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 212
TRATTAMENTO E PREVENZIONE DI MALATTIE CARDIOVASCOLARI CON ACIDO ERUCICO E METODI DIAGNOSTICI CORRELATI 212
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 211
A unique exon specific U1snRNA rescues different haemophilia B - causing splicing-defective factor IX variants in mice 211
Psychiatric disorder in a familial 15;18 translocation and sublocalization of myelin basic protein of 18q22.3 209
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 208
Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 207
A new factor V gene polymorphism (His 1254 Arg) present in subjects of African origin mimics the R2 polymorphism (His 1299 Arg) 206
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 206
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 204
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 204
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): Study protocol for a randomized controlled trial 204
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 203
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 203
The dominant-negative von Willebrand factor gene deletion p.P1127-C1948delinsR: Molecular mechanism and modulation 203
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 203
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations 202
Acute Coronaric Syndroms and FVII polymorphisms: different effects in the same gene 200
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 199
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 199
A novel factor V null mutation detected in a thrombophilic patient with pseudo-homozygous APC resistance and in an asymptomatic unrelated subject 198
Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma 198
The factor V Glu1608Lys mutation is recurrent in familial thrombophilia 197
Ribosome readthrough accounts for secreted full-length factor IX in hemophilia B patients with nonsense mutations 197
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 197
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 195
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 195
Correction of aberrant splicing causing haemophilia B through the combination of compensatory U1snRNAs and antisense oligonucleotides 195
A family study of FVII genotype, elevated levels of factor VII and arterial thrombotic disease 194
Residual factor VII activity and different hemorrhagic phenotypes in CRM+ factor VII deficiencies (Gly331Ser and Gly283Ser) 192
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 192
The complete impairment of factor VII gene expression by the IVS6+1g/t mutation is compatible with a severe but not lethal bleeding disorder 192
Plasma levels of soluble NCAM in multiple sclerosis 192
Performance prediction models based on anthropometric, genetic and psychological traits of Croatian sprinters 192
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 191
Circadian rhythms in mouse blood coagulation 190
Temporal variations of coagulation factor VII activity in mice are influenced by lighting regime 190
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala(223)Val MTHFR) in patients with inherited thrombophilic coagulation defects 188
A RECURRENT AMINOACID SUBSTITUTION AND A PARTIAL GENE DELETION IN SEVERE HEMOPHILIA A 188
Factor II Activity is Similarly Increased in Patients with Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 188
Organization of α-Globin Genes and mRNA Translation in Subjects Carrying Haemoglobin Hasharon (α47 Asp → His) from the Ferrara Region (Northern Italy) 187
Variation of factor VII 140s and 170s loops in fishes: evolutionary aspects and comparison with mutations found in FVII deficiency 187
A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide 187
Aberrant splicing reverts a potentially lethal coagulation deficiency caused by a +1g/t splicing mutation 187
Partial gene deletion in a family with factor X deficiency 187
Totale 24.507
Salva come PNG Salva come JPEG
Categoria #
all - tutte 302.971
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.978
Totale 304.949
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.026 0 0 0 0 0 0 0 0 0 0 735 291
2021/20224.434 245 482 276 246 261 178 206 211 138 344 391 1.456
2022/20234.440 488 342 109 583 726 661 211 356 543 39 244 138
2023/20242.348 203 277 110 81 166 433 65 154 59 56 64 680
2024/20259.468 266 186 817 272 1.175 920 242 468 1.492 1.197 1.356 1.077
2025/202628.104 2.588 1.191 2.610 3.726 4.020 1.831 3.329 1.476 4.398 2.817 118 0
Totale 71.842